InvestorsHub Logo
icon url

GD

08/16/20 10:25 PM

#32921 RE: Biobonic #32920

As I posted before, I have no problem CVM wants complete
analysis data and err on the side of being conservative,
I have issue with Geert's plan to PR the complete data
to public at first time, which is not "err on the side
of being conservative", just the opposite, and means to
me the the results are borderline on efficacy, Soxrates
expresses this view much better than I do. I may be wrong on
this PR issue, but my instinct tells me something
changed from the CEO Geert I heard on many presentations.